Lead Biostatistician, Oncology - Hematologic Malignancies

IQVIA; Zaventem; Sur place; EUR 120 000 - 160 000; Plein temps

Résumé du poste

IQVIA in Belgium seeks a Principal Biostatistician to provide strategic statistical leadership for oncology clinical development, with a focus on hematological malignancies such as multiple myeloma, leukemia, and lymphoma. You will partner with cross-functional teams to shape study design and deliver high-quality statistics.

This role requires deep CDISC SDTM expertise, oversight of SDTM datasets, and effective communication with regulators and stakeholders to ensure timely, compliant results

Qualifications

• Advanced experience as a Principal Biostatistician in pharma/biotech/CRO.
• Strong oncology development experience.
• Expertise in hematological malignancies: multiple myeloma, leukemia, lymphoma.
• Proficient in CDISC SDTM standards.
• Experience QC-ing SDTM datasets and outputs.
• Excellent communication and cross-functional teamwork.

Responsabilités

• Provide Principal-level Biostatistics leadership for Oncology development programs and studies.
• Lead statistical activities across trials and act as primary statistician on assigned studies.
• Review QC of SDTM datasets and deliverables for CDISC compliance.
• Collaborate with Programming, Data Management, Clinical Operations, and Regulatory teams.

Connaissances

Biostatistics leadership

Oncology development

Hematological malignancies

CDISC SDTM

Study design

Cross-functional collaboration

Statistical interpretation

Outils

R

SAS

SDTM tools

Description du poste

IQVIA in Belgium seeks a Principal Biostatistician to provide strategic statistical leadership for oncology clinical development, with a focus on hematological malignancies such as multiple myeloma, leukemia, and lymphoma. You will partner with cross-functional teams to shape study design and deliver high-quality statistics.

This role requires deep CDISC SDTM expertise, oversight of SDTM datasets, and effective communication with regulators and stakeholders to ensure timely, compliant results